NX-06

N/A

Report date: 2022/06/22 13:56:30

Base Information

Drug NameNX-06

Drug Alias NameNX-06

ClassificationBiologics > Protein drugs > Immunoglobulin > Antibody > Antibody fragment > Single-domain antibody (Nanobody)Biologics > Protein drugs > Recombinant protein > Fusion protein

Mechanisms of ActionUpdating

TargetsUpdating

Therapy Area/IndicationsThromboembolism

Global Approved IndicationsN/A

Approved Indications in ChinaN/A

Original Approved Country/TerritoryN/A

Original Approved DateN/A

Country/TerritoryN/A

CombinationsNo

Global Highest StatusPreclinical

Highest Status in ChinaN/A

Originator CompaniesZhuangya (Beijing) Biotechnology Co Ltd

China Registration ClassN/A

Develop Information

Active CompaniesZhuangya (Beijing) Biotechnology Co Ltd

Inactive CompaniesN/A

Active IndicationsThromboembolism

Inactive IndicationsN/A

Other Information

ATC CodeN/A